Skip to main content
. 2021 Aug 20;100(33):e26951. doi: 10.1097/MD.0000000000026951

Figure 2.

Figure 2

Analysis of the overall survival and disease-free survival rates based on SKP2 expression in gastric adenocarcinoma. A. The patients with a positive SKP2 expression showed a significantly higher cumulative survival rate than patients with a negative SKP2 expression in gastric adenocarcinoma (P = .007). B. The patients with a positive SKP2 expression showed a significantly higher disease-free survival rate than the patients with a negative SKP2 expression (P < .0001). C. The patients with a positive SKP2 expression presented a significantly higher disease-free survival rate than the patients with a negative SKP2 expression among the tumoral FOXP3 population (P < .001). D. Difference in disease-free survival between positive SKP2 expression and negative SKP2 expression is attenuated among tumoral FOXP3 population (P = .419). FOXP3 = forkhead box protein P3, SKP2 = S-phase kinase-associated protein 2.